Haleon plc (NYSE:HLN) Receives $10.95 Average Price Target from Brokerages

Shares of Haleon plc (NYSE:HLN) have earned a consensus rating of “Moderate Buy” from the eight analysts that are covering the company, MarketBeat Ratings reports. Five research analysts have rated the stock with a hold recommendation, two have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year target price among brokerages that have issued a report on the stock in the last year is $10.95.

HLN has been the subject of several research reports. HSBC restated a “hold” rating on shares of Haleon in a report on Wednesday. Morgan Stanley lowered shares of Haleon from an “overweight” rating to an “equal weight” rating in a report on Friday, January 10th. Sanford C. Bernstein cut Haleon from an “outperform” rating to a “market perform” rating in a research report on Wednesday, January 8th. Finally, Hsbc Global Res lowered Haleon from a “strong-buy” rating to a “hold” rating in a research report on Wednesday.

Haleon Trading Down 1.5 %

Shares of HLN opened at $10.39 on Friday. The stock has a market capitalization of $47.02 billion, a P/E ratio of 30.55, a PEG ratio of 2.82 and a beta of 0.25. Haleon has a twelve month low of $7.89 and a twelve month high of $10.80. The company has a quick ratio of 0.58, a current ratio of 0.84 and a debt-to-equity ratio of 0.44. The firm has a fifty day simple moving average of $9.65 and a two-hundred day simple moving average of $9.85.

Haleon (NYSE:HLN) last posted its earnings results on Thursday, February 27th. The company reported $0.05 earnings per share for the quarter. The company had revenue of $3.54 billion during the quarter, compared to analyst estimates of $3.38 billion. Haleon had a net margin of 10.85% and a return on equity of 14.76%. On average, research analysts anticipate that Haleon will post 0.43 EPS for the current year.

Haleon Increases Dividend

The firm also recently announced a — dividend, which will be paid on Thursday, June 5th. Shareholders of record on Friday, April 25th will be issued a dividend of $0.1166 per share. This is a boost from Haleon’s previous — dividend of $0.05. This represents a yield of 1.6%. The ex-dividend date of this dividend is Friday, April 25th. Haleon’s dividend payout ratio is currently 58.97%.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the company. Procyon Advisors LLC lifted its holdings in shares of Haleon by 41.3% in the fourth quarter. Procyon Advisors LLC now owns 230,240 shares of the company’s stock worth $2,196,000 after buying an additional 67,329 shares in the last quarter. HighTower Advisors LLC increased its holdings in Haleon by 27.2% in the 3rd quarter. HighTower Advisors LLC now owns 350,795 shares of the company’s stock valued at $3,701,000 after acquiring an additional 74,970 shares during the last quarter. Jane Street Group LLC lifted its stake in Haleon by 1,689.4% in the 3rd quarter. Jane Street Group LLC now owns 264,977 shares of the company’s stock worth $2,803,000 after purchasing an additional 250,169 shares in the last quarter. Chartwell Investment Partners LLC grew its position in shares of Haleon by 107.8% during the third quarter. Chartwell Investment Partners LLC now owns 475,415 shares of the company’s stock valued at $5,030,000 after purchasing an additional 246,594 shares in the last quarter. Finally, Townsquare Capital LLC increased its holdings in shares of Haleon by 29.8% in the third quarter. Townsquare Capital LLC now owns 475,618 shares of the company’s stock worth $5,032,000 after purchasing an additional 109,217 shares during the last quarter. Hedge funds and other institutional investors own 6.67% of the company’s stock.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.